Is retatrutide legal in the UK? The law in plain English

Retatrutide is not a controlled drug, so having it is not a crime. It is an unlicensed medicine, so selling, supplying or advertising it for people to use is an offence. This page explains the difference in plain English. It is general information, not legal advice.

Not a controlled drug

The Misuse of Drugs Act 1971 is the law behind the phrases "Class A, B and C". It lists substances such as heroin, cocaine and diazepam and makes possessing them an offence in itself. Retatrutide is not on that list. Neither are semaglutide or tirzepatide.^[1] That is why the word controlled drug does not apply, and why simply having a vial does not put you on the wrong side of the criminal law.

That is where the reassurance ends.

But it is an unlicensed medicine

Medicines in the UK are governed by the Human Medicines Regulations 2012. Before a medicine can be put on the market it needs a marketing authorisation from the MHRA, granted after the regulator has reviewed evidence on quality, safety and effectiveness.

Retatrutide is an investigational medicine. Lilly is still running Phase 3 trials and has not applied for a licence anywhere.^[2] That makes it an unlicensed medicine. Under the Regulations an unlicensed medicine cannot be sold or supplied to the public, and it cannot be advertised.^[3] There are narrow exceptions, for approved clinical trials and for "specials" made by licensed manufacturers for individual patients. A website or a social media account selling vials to the public is neither.

Even the licensed relatives of retatrutide sit in the most restricted of the three UK classes of medicine. Semaglutide and tirzepatide are prescription-only, which means they can lawfully be supplied only after an assessment by a qualified prescriber.^[7][8]

Possession versus supply

The Regulations target the supply chain, not the end user. The offences are about selling, offering to sell, supplying, advertising, manufacturing and importing for those purposes.^[3] Possessing a medicine for your own use is not one of them.

"Supply" is wider than most people think. Passing a vial to a friend is supply, even if no money changes hands. Ordering for a group and handing the vials round is supply. Advertising in a group chat is advertising. The person who did those things is the one the law is aimed at, not the person who received the vial.

"Research use only" and "not for human consumption"

Most products sold as retatrutide carry a label saying they are for research use only. The label is a legal strategy, not a description of what happens next.

The MHRA does not decide whether something is a medicine by reading its label. Its borderline guidance says it looks at the claims made about the product, the properties of its ingredients, its primary intended purpose and the way people would actually use it, and how it is presented to the public through labelling, packaging, promotional literature, advertisements, websites, social media and customer reviews.^[4] The legal definition of a medicinal product covers any substance presented as treating a condition, or given to people to modify how their body works.^[3]

A vial sold in weight-loss groups, with weight-loss claims in the listing and people describing their weight loss underneath, is presented for human use. The "research" label does not change its status once it is being sold to people to inject. The MHRA raids described on the enforcement page involved products of exactly this kind.

"Unlicensed" versus "off-label"

These two words are often mixed up.

• Off-label means a licensed medicine is being prescribed outside the terms of its licence: a different condition, dose or age group. Doctors may do this on their own professional responsibility, and it is common. It only applies to a medicine that has a licence.
• Unlicensed means the medicine has no licence at all. Retatrutide is unlicensed. It cannot be prescribed off-label, because there is no label to go off. The only lawful way to receive it is inside an approved trial.

Importing for personal use

The offences in the Regulations are about sale, supply and advertising. Bringing a small quantity of an unlicensed medicine into the country for your own use is generally not, by itself, treated as a criminal offence. That is not the same as it being allowed through, and it is not the same as it being safe.

The MHRA and Border Force run joint operations on parcels entering the UK. In a two-week operation in March 2026 they seized more than two million doses of illicit medicines.^[9] A parcel of unlicensed injectables can be stopped and destroyed, and you have no comeback against the seller. The MHRA's advice is not to obtain weight-loss medicines from unregulated websites or social media at all.^[8] This site does not describe how importing is done.

The MHRA's stated position

When it announced the Northampton raid in October 2025, the MHRA said retatrutide "has not been approved for UK use" and that, outside authorised clinical trials, any products sold in the UK claiming to contain it "are likely to be illegal and are potentially dangerous to people's health".^[5] It has separately said retatrutide "cannot be legally supplied outside of ongoing clinical trials".^[10] Its general guidance on GLP-1 medicines warns against obtaining them from beauty salons, social media or anywhere without a prior consultation with a healthcare professional.^[11]

What this means in practice

For a person who has used or has a product

You have not committed an offence by having it or using it. Nobody in the NHS will report you for saying what you used, and the information helps them look after you. The risk you carry is medical, not legal: see what is actually in the vials and talking to your GP.

For a seller

Selling, supplying or advertising retatrutide for human use is an offence under the 2012 Regulations, whatever the label says.^[3] The MHRA's Criminal Enforcement Unit investigates, raids premises, seizes stock and cash, and arrests people.^[6]

For clinics, aesthetics practices and "med spas"

A clinic that gives or sells retatrutide is supplying an unlicensed medicine outside a trial. A private prescription does not change that: "specials" are a narrow route for licensed manufacturers to make unlicensed medicines for individual patients when no licensed medicine will do, and the MHRA's position is that retatrutide cannot lawfully be supplied outside a trial.^[10] If a clinic offers it, the clinic is the one taking the legal risk, and you are the one taking the medical risk.